Benzoic acid, 4-(butylamino)-, 2-[(4-chlorophenyl)methylene]hydrazide manufacturers
|
| | Benzoic acid, 4-(butylamino)-, 2-[(4-chlorophenyl)methylene]hydrazide Basic information |
| | Benzoic acid, 4-(butylamino)-, 2-[(4-chlorophenyl)methylene]hydrazide Chemical Properties |
| density | 1.15±0.1 g/cm3(Temp: 20 °C; Press: 760 Torr)(Predicted) | | pka | 12.66±0.46(Predicted) |
| | Benzoic acid, 4-(butylamino)-, 2-[(4-chlorophenyl)methylene]hydrazide Usage And Synthesis |
| Uses | Anticancer agent 100 is a derivative of tetracaine with anti-cancer activity and can be used in cancer research[1]. | | References | [1] Han M, et al. Design, Synthesis, and Anticancer Evaluation of Novel Tetracaine Hydrazide-Hydrazones. ACS Omega. 2023 Feb 28;8(10):9198-9211. DOI:10.1021/acsomega.2c07192 |
| | Benzoic acid, 4-(butylamino)-, 2-[(4-chlorophenyl)methylene]hydrazide Preparation Products And Raw materials |
|